Guillermo Peluffo

Guillermo Peluffo

UNVERIFIED PROFILE

Are you Guillermo Peluffo?   Register this Author

Register author
Guillermo Peluffo

Guillermo Peluffo

Publications by authors named "Guillermo Peluffo"

Are you Guillermo Peluffo?   Register this Author

9Publications

148Reads

10Profile Views

KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance.

Cancer Cell 2018 12 21;34(6):939-953.e9. Epub 2018 Nov 21.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, MA 02215, USA; The Eli and Edythe L Broad Institute of MIT and Harvard, Cambridge, MA 02139, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Ludwig Center at Harvard, Boston, MA 02215, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15356108183048
Publisher Site
http://dx.doi.org/10.1016/j.ccell.2018.10.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310147PMC
December 2018

JARID1B is a luminal lineage-driving oncogene in breast cancer.

Cancer Cell 2014 Jun;25(6):762-77

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; Broad Institute, Cambridge, MA 02141, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccr.2014.04.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079039PMC
June 2014

Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast.

Proc Natl Acad Sci U S A 2009 Mar 13;106(9):3372-7. Epub 2009 Feb 13.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0813306106DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2642666PMC
March 2009

Inhibition of tumor progression and paraneoplastic syndrome development in a murine lung adenocarcinoma by medroxyprogesterone acetate and indomethacin.

Cancer Invest 2006 Mar;24(2):126-31

Animal Care and Experimental Cancer Department, Angel H. Roffo Institute of Oncology, University of Buenos Aires, Buenos Aires, Argentina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07357900500524322DOI Listing
March 2006

Reduction of tumor progression and paraneoplastic syndrome development in murine lung adenocarcinoma by nonsteroidal antiinflammatory drugs.

Int J Cancer 2004 Jul;110(6):825-30

Departamento Bioterio y Cáncer Experimental, Area Investigación, Instituto de Oncología Angel H. Roffo, Universidad de Buenos Aires, Av. San Martín 5481, 1417 Buenos Aires, Argentina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.20226DOI Listing
July 2004

Effects of celecoxib, medroxyprogesterone, and dietary intervention on systemic syndromes in patients with advanced lung adenocarcinoma: a pilot study.

J Pain Symptom Manage 2004 Jan;27(1):85-95

Supportive Care Division, Angel H. Roffo Cancer Institute, University of Buenos Aires, Buenos Aires, Argentina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpainsymman.2003.05.010DOI Listing
January 2004